Exelixis at Jefferies Global Healthcare Conference: zanza buildout in focus Investing.com · News 10m ago
Hims & Hers launches new peptide treatments — while admitting there's more to learn about efficacy CNBC · Economy 12m ago
Compass Therapeutics’ chief accounting officer Neil Lerner buys $5,900 in stock Investing.com · News 13m ago
Proficient Auto Logistics president and COO Amy Rice purchases $8,568 stock Investing.com · News 14m ago
Earnings call transcript: Einride posts strong Q3 2026 growth as stock falls premarket Investing.com · News 14m ago
Applied Materials vs. Marvell Technology: Which Tech Stock Is a Better Buy for 2027? NASDAQ · Markets 17m ago